You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy

Article info

Article menu

Download PDFPDF

XML
Case Report
Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy

Authors

  • Michael Lattanzi Department of MedicineNYU Langone Health New York NY USA PubMed articlesGoogle scholar articles
  • Fang-Ming Deng Department of PathologyNYU Langone Health New York NY USA Department of UrologyNYU Langone Health New York NY USA Laura and Isaac Perlmutter Cancer CenterNYU Langone Health New York NY USA PubMed articlesGoogle scholar articles
  • Luis A. Chiriboga Department of PathologyNYU Langone Health New York NY USA PubMed articlesGoogle scholar articles
  • Alisa N. Femia Ronald O. Perelman Department of DermatologyNYU Langone Health New York NY USA PubMed articlesGoogle scholar articles
  • Shane A. Meehan Department of PathologyNYU Langone Health New York NY USA Ronald O. Perelman Department of DermatologyNYU Langone Health New York NY USA PubMed articlesGoogle scholar articles
  • Gopa Iyer Department of MedicineMemorial Sloan-Kettering Cancer Center New York NY USA PubMed articlesGoogle scholar articles
  • Martin H. Voss Department of MedicineMemorial Sloan-Kettering Cancer Center New York NY USA PubMed articlesGoogle scholar articles
  • Yuliya Sundatova Laura and Isaac Perlmutter Cancer CenterNYU Langone Health New York NY USA Genitourinary Medical Oncology ProgramNYU School of Medicine, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health 160 East 34th Street, 10th Floor 10016 New York NY USA PubMed articlesGoogle scholar articles
  • William C. Huang Department of UrologyNYU Langone Health New York NY USA Laura and Isaac Perlmutter Cancer CenterNYU Langone Health New York NY USA PubMed articlesGoogle scholar articles
  • Arjun V. Balar Department of MedicineNYU Langone Health New York NY USA Laura and Isaac Perlmutter Cancer CenterNYU Langone Health New York NY USA Genitourinary Medical Oncology ProgramNYU School of Medicine, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health 160 East 34th Street, 10th Floor 10016 New York NY USA PubMed articlesGoogle scholar articles
  1. ↵a Michael.Lattanzi{at}nyumc.org
  2. ↵b Fang-Ming.Deng{at}nyumc.org
  3. ↵c Luis.Chiriboga{at}nyumc.org
  4. ↵d Alisa.Femia{at}nyumc.org
  5. ↵e Shane.Meehan{at}nyumc.org
  6. ↵f iyerg{at}mskcc.org
  7. ↵g vossm{at}mskcc.org
  8. ↵h Yuliya.Sundatova{at}nyumc.org
  9. ↵i William.Huang{at}nyumc.org
  10. ↵j 212-731-5820 Arjun.Balar{at}nyumc.org
View Full Text

Citation

Lattanzi M, Deng F, Chiriboga LA, et al
Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy
Journal for ImmunoTherapy of Cancer 2018;6:97. doi: 10.1186/s40425-018-0415-x

Publication history

  • Received June 15, 2018
  • Accepted September 18, 2018
  • First published October 1, 2018.
Online issue publication 
January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.